Display title | Translations:HRT/58/en |
Default sort key | HRT/58/en |
Page length (in bytes) | 645 |
Namespace ID | 1198 |
Namespace | Translations |
Page ID | 326 |
Page content language | en - English |
Page content model | wikitext |
Indexing by robots | Disallowed |
Number of redirects to this page | 0 |
Number of subpages of this page | 0 (0 redirects; 0 non-redirects) |
Edit | Allow only users with "translate" permission (infinite) |
Move | Allow only users with "translate" permission (infinite) |
Page creator | FuzzyBot (talk | contribs) |
Date of page creation | 16:53, 24 September 2024 |
Latest editor | FuzzyBot (talk | contribs) |
Date of latest edit | 15:24, 13 November 2024 |
Total number of edits | 2 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |
Description | Content |
Article description: (description ) This attribute controls the content of the description and og:description elements. | Note that bicalutamide, unlike most other anti-androgens, does not lower testosterone levels, in fact they usually rise as the body responds to testosterone receptors being inhibited. Do not be alarmed if you notice an increase of testosterone in your blood tests.
|-
| |